Biohit Investor Relations Material
Latest events
H2 2024
12 Feb, 2025
H1 2024
7 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Biohit Oyj
Access all reports
Biohit Oyj is a Finland-based biotechnology company specializing in the development and production of diagnostic tests and laboratory instruments. The company’s product portfolio includes enzyme immunoassay tests, liquid handling devices, and solutions for the detection and monitoring of gastrointestinal diseases and conditions. The company is headquartered in Helsinki, Finland, and its shares are listed on the Nasdaq Helsinki.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
BIOBV
Country
🇫🇮 Finland